NOVARTIS INDIA Financial Statement Analysis
|
||
|
The Revenues of NOVARTIS INDIA have decreased by -11.53% YoY .
The Earnings Per Share (EPS) of NOVARTIS INDIA has increased by 18.42 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
NOVARTIS INDIA Last 5 Annual Financial Results
[BOM: 500672|NSE : NOVARTIND]
| Standalone | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|---|
| Revenues | ₹335 Cr | ₹379 Cr | ₹400 Cr | ₹381 Cr | ₹438 Cr |
| Expenses | ₹270 Cr | ₹314 Cr | ₹373 Cr | ₹356 Cr | ₹427 Cr |
| Operating Profit (Excl OI) | ₹65 Cr | ₹65 Cr | ₹27 Cr | ₹26 Cr | ₹12 Cr |
| Other Income | ₹62 Cr | ₹58 Cr | ₹34 Cr | ₹34 Cr | ₹36 Cr |
| Interest | ₹1.49 Cr | ₹1.75 Cr | ₹4.83 Cr | ₹7.68 Cr | ₹6.39 Cr |
| Depreciation | ₹2.61 Cr | ₹6.06 Cr | ₹9.65 Cr | ₹12 Cr | ₹13 Cr |
| Profit Before Tax | ₹123 Cr | ₹115 Cr | ₹-3.82 Cr | ₹40 Cr | ₹29 Cr |
| Profit After Tax | ₹85 Cr | ₹103 Cr | ₹-3.72 Cr | ₹21 Cr | ₹10 Cr |
| Earnings Per Share (Rs) | ₹40.88 | ₹34.52 | ₹41.88 | ₹-1.51 | ₹8.47 |
| PAT Margin (%) | 25.87 | 23.22 | 25.00 | -0.76 | 4.61 |
| ROE(%) | 13.19 | 11.21 | 14.07 | -0.53 | 2.91 |
| ROCE(%) | 17.15 | 16.35 | 15.96 | 0.14 | 6.67 |
| Total Debt/Equity(x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Key Financials |
||
| Market Cap | : | ₹ 2,305.3 Cr |
| Revenue (TTM) | : | ₹ 351.5 Cr |
| Net Profit(TTM) | : | ₹ 102.8 Cr |
| EPS (TTM) | : | ₹ 41.6 |
| P/E (TTM) | : | 22.4 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| NOVARTIS INDIA | -0.5% | -6.3% | -16.9% |
| ADANI ENTERPRISES | -0.8% | -9.8% | -25.8% |
| REDINGTON | 0.2% | -8.1% | 17.7% |
| MMTC | -2.5% | -5.2% | -40.7% |
| HONASA CONSUMER | -0% | 11.2% | -42.8% |
| LLOYDS ENTERPRISES | -2.2% | -2.4% | 81.4% |
| ENTERO HEALTHCARE SOLUTIONS | -1.4% | -7.3% | -9.8% |
| OPTIEMUS INFRACOM | 1.1% | -0.2% | -6.1% |
| POLO QUEEN INDUSTRIAL & FINTECH | -5.4% | -5.8% | 1.4% |
NOVARTIS INDIA Revenues
[BOM: 500672|NSE : NOVARTIND]
| Y-o-Y | -11.53 % |
| 5 Yr CAGR | -6.49 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹335 Cr | -11.53 | |
| Mar2024 | ₹379 Cr | -5.28 | |
| Mar2023 | ₹400 Cr | 4.86 | |
| Mar2022 | ₹381 Cr | -12.98 | |
| Mar2021 | ₹438 Cr | - | |
NOVARTIS INDIA Operating Profit
[BOM: 500672|NSE : NOVARTIND]
| Y-o-Y | 0.28 % |
| 5 Yr CAGR | 53.55 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹65 Cr | 0.28 | |
| Mar2024 | ₹65 Cr | 143.29 | |
| Mar2023 | ₹27 Cr | 4.13 | |
| Mar2022 | ₹26 Cr | 118.82 | |
| Mar2021 | ₹12 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 13.39 % |
| 5 Yr CAGR | 64.20 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | 19.48% | 13.39 | |
| Mar2024 | 17.18% | 156.80 | |
| Mar2023 | 6.69% | -0.74 | |
| Mar2022 | 6.74% | 151.49 | |
| Mar2021 | 2.68% | - | |
NOVARTIS INDIA Profit After Tax
[BOM: 500672|NSE : NOVARTIND]
| Y-o-Y | -17.58 % |
| 5 Yr CAGR | 70.50 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹85 Cr | -17.58 | |
| Mar2024 | ₹103 Cr | Positive | |
| Mar2023 | ₹-3.72 Cr | Negative | |
| Mar2022 | ₹21 Cr | 107.34 | |
| Mar2021 | ₹10 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 11.41 % |
| 5 Yr CAGR | 53.91 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | 25.87 % | 11.41 | |
| Mar2024 | 23.22 % | -7.12 | |
| Mar2023 | 25 % | Positive | |
| Mar2022 | -0.76 % | Negative | |
| Mar2021 | 4.61 % | - | |
NOVARTIS INDIA Earnings Per Share (EPS)
[BOM: 500672|NSE : NOVARTIND]
| Y-o-Y | 18.42 % |
| 5 Yr CAGR | 48.22 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹41 | 18.42 | |
| Mar2024 | ₹35 | -17.57 | |
| Mar2023 | ₹42 | Positive | |
| Mar2022 | ₹-1.51 | Negative | |
| Mar2021 | ₹8.47 | - | |
NOVARTIS INDIA Return on Capital Employed (ROCE)
[BOM: 500672|NSE : NOVARTIND]
| Y-o-Y | 4.89 % |
| 5 Yr CAGR | 26.63 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | 17.15% | 4.89 | |
| Mar2024 | 16.35% | 2.44 | |
| Mar2023 | 15.96% | 11,300.00 | |
| Mar2022 | 0.14% | -97.90 | |
| Mar2021 | 6.67% | - | |
NOVARTIS INDIA Share Price vs Sensex
| Current Share Price | : | ₹933.3 |
| Current MarketCap | : | ₹ 2,305.3 Cr |
| Updated EOD on | : | Sep 01,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NOVARTIS INDIA | -0.5% |
-6.3% |
-16.9% |
| SENSEX | -1.2% |
-1.2% |
-1.7% |
NOVARTIS INDIA related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE ALLCAP | 6.4% | 8.9% | 7.5% |
| BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
| BSE SMALLCAP | -1.5% | -2.9% | -6.9% |
| BSE HEALTHCARE | -2.3% | -4.5% | 3.4% |
No NSE index found
You may also like the below Video Courses
FAQ about NOVARTIS INDIA Financials
How the annual revenues of NOVARTIS INDIA have changed ?
The Revenues of NOVARTIS INDIA have decreased by -11.53% YoY .
How the Earnings per Share (EPS) of NOVARTIS INDIA have changed?
The Earnings Per Share (EPS) of NOVARTIS INDIA has increased by 18.42 % YoY .
Check out Intrinsic Value of Peers of NOVARTIS INDIA
|
Intrinsic Value of ADANI ENTERPRISES LTD Intrinsic Value of REDINGTON LTD Intrinsic Value of MMTC LTD Intrinsic Value of HONASA CONSUMER LTD Intrinsic Value of LLOYDS ENTERPRISES LTD |
Compare Stock Analytics of Peers of NOVARTIS INDIA
ADANI ENTERPRISES LTD vs REDINGTON LTD vs MMTC LTD
HONASA CONSUMER LTD vs LLOYDS ENTERPRISES LTD vs
ADANI ENTERPRISES LTD vs REDINGTON LTD vs MMTC LTD
HONASA CONSUMER LTD vs LLOYDS ENTERPRISES LTD vs
